| Title: |
Thyroid Hormone Replacement in Patients Following Thyroidectomy for Thyroid Cancer. |
| Authors: |
Hannoush, Zeina C.1, Weiss, Roy E.1 rweiss@med.miami.edu |
| Source: |
Rambam Maimonides Medical Journal. Jan2016, Vol. 7 Issue 1, p1-9. 9p. |
| Subject Terms: |
*HYPOTHYROIDISM treatment, *THYROID cancer patients, *THYROID hormones |
| Abstract: |
Thyroid hormone replacement therapy in patients following thyroidectomy for thyroid cancer, although a potentially straightforward clinical problem, can present the clinician and patient with a variety of challenges. Most often the problems are related to the dose and preparation of thyroid hormone (TH) to use. Some patients feel less well following thyroidectomy and/or radioiodine ablation than they did before their diagnosis. We present evidence that levothyroxine (L-T4) is the preparation of choice, and keeping the thyroid-stimulating hormone (TSH) between detectable and 0.1 mU/L should be the standard of care in most cases. In unusual circumstances, when the patient remains clinically hypothyroid despite a suppressed TSH, we acknowledge there may be as yet unidentified factors influencing the body's response to TH, and individualized therapy may be necessary in such patients. [ABSTRACT FROM AUTHOR] |
|
Copyright of Rambam Maimonides Medical Journal is the property of Rambam Health Care Campus and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
